Monthly Prescribing Reference11h
FDA Extends Review of DCCR for Prader-Willi Syndrome
According to Soleno Therapeutics, the FDA required more time to review responses to recent information requests.
Monthly Prescribing Reference11h
FDA to Review Resubmitted Dihydroergotamine Nasal Powder NDA for Migraine
STS101 is an investigational DHE nasal powder product administered through a proprietary nasal delivery device.
Monthly Prescribing Reference17h
Studies Examine Cost-Effectiveness of Maternal RSV Vaccination, Nirsevimab in Infants
Seasonal maternal RSV vaccination may be cost-effective, as well as nirsevimab, particularly for those with higher risks ...
Monthly Prescribing Reference18h
In Utero Exposure to Certain Antiepileptics Tied to Neurodevelopmental Diagnoses
(HealthDay News) — Exposure to certain antiseizure medications (ASMs) in utero is associated with an increased likelihood of neurodevelopmental diagnoses, according to a study published online Nov. 15 ...